0001849201-21-000001.txt : 20210304 0001849201-21-000001.hdr.sgml : 20210304 20210304101905 ACCESSION NUMBER: 0001849201-21-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20210304 DATE AS OF CHANGE: 20210304 EFFECTIVENESS DATE: 20210304 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Neurexis Therapeutics, Inc. CENTRAL INDEX KEY: 0001849201 IRS NUMBER: 844854116 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-391198 FILM NUMBER: 21712850 BUSINESS ADDRESS: STREET 1: 12635 E MOUNTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 BUSINESS PHONE: 4795712592 MAIL ADDRESS: STREET 1: 12635 E MOUNTVIEW BLVD. STREET 2: SUITE 100 CITY: AURORA STATE: CO ZIP: 80045 D 1 primary_doc.xml X0708 D LIVE 0001849201 Neurexis Therapeutics, Inc. 12635 E MOUNTVIEW BLVD. SUITE 100 AURORA CO COLORADO 80045 4795712592 DELAWARE None None Corporation true 2020 Michael Artinger 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Executive Officer Director Robert Calvin Goforth 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Director Ulli Bayer 535 W. Research Center Blvd. Suite 135 Fayetteville AR ARKANSAS 72701 Director Other Decline to Disclose 06b false 2021-02-26 false true false 0 None None None None N/A N/A Fayetteville AR ARKANSAS 72701 AR ARKANSAS false 500000 500000 0 false 1 0 0 0 false Neurexis Therapeutics, Inc. Michael Artinger Michael Artinger Chief Executive Officer 2021-03-04